The Zacks Analyst Blog Highlights Johnson & Johnson, Oracle, HSBC, NVIDIA and The Cigna Group
For Immediate Release
Chicago, IL – June 13, 2023 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Johnson & Johnson JNJ, Oracle Corporation ORCL, HSBC Holdings plc HSBC, NVIDIA Corporation NVDA and The Cigna Group CI.
Here are highlights from Monday’s Analyst Blog:
Top Research Reports for Johnson & Johnson, Oracle & HSBC
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson, Oracle Corporation and HSBC Holdings plc. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Shares of Johnson & Johnson have underperformed the Zacks Large Cap Pharmaceuticals industry over the year-to-date period (-8.1% vs. +2.2%). The company is facing headwinds like generic competition, pricing pressures and loss of exclusivity of on key drugs like Stelara. Though J&J has taken meaningful steps to resolve its talc and opioid litigation, it continues to remain an overhang on the stock.
Nevetheless, J&J’s Pharma unit is performing at above-market levels. Growth in 2023 is expected to be driven by existing products like Darzalex, Tremfya, Erleada, Invega Sustenna and Uptravi, and also continued uptake from new launches, including Spravato, Carvykti and Tecvayli.
The MedTech unit is showing improving trends, driven by recovery in surgical procedures and contribution from new products. J&J is making rapid progress with its pipeline and line extensions.
(You can read the full research report on Johnson & Johnson here >>>)
Oracle shares have outperformed the Zacks Computer - Software industry over the past year (+74.5% vs. +36.0%). The company is benefiting from the ongoing momentum across its cloud business, driven by the strong uptake of Oracle Cloud Infrastructure services and Autonomous Database offerings. We expect these trends to be further confirmed following the company's results later this afternoon.
Solid adoption of cloud-based applications, comprising NetSuite Enterprise Resource Planning (ERP), Fusion ERP and Fusion Human Capital Management (HCM), bodes well. Solid demand for the Oracle Dedicated Region Cloud@Customer is anticipated to drive the top line. Partnerships with Accenture and Microsoft is helping Oracle win new clientele.
However, higher spending on product enhancements, especially toward the cloud platform, amid increasing competition in the cloud domain is likely to limit margin expansion.
(You can read the full research report on Oracle here >>>)
Shares of HSBC have outperformed the Zacks Banks - Foreign industry over the past year (+32.8% vs. +15.1%). The company’s strong capital position, higher rates, an extensive network and business restructuring initiatives will aid HSBC’s financials. The company’s strong brand value and widespread network will help it attract more clients.
HSBC’s plan to exit from the U.S., French and Canadian retail banking business is expected to help it focus more on Asia. Also, buyouts of AXA Singapore insurance assets and L&T Investment Management Limited will expand its presence in the region.
Although efforts to improve market share in the region will support financials, these will lead to a rise in expenses. Management expects expenses to rise 3% this year, and the recent growth initiatives will likely add another 1%. The worsening operating backdrop is another headwind.
(You can read the full research report on HSBC here >>>)
Other noteworthy reports we are featuring today include NVIDIA Corporation and The Cigna Group.
Why Haven’t You Looked at Zacks' Top Stocks?
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Johnson & Johnson (JNJ) : Free Stock Analysis Report
NVIDIA Corporation (NVDA) : Free Stock Analysis Report
Cigna Group (CI) : Free Stock Analysis Report
Oracle Corporation (ORCL) : Free Stock Analysis Report
HSBC Holdings plc (HSBC) : Free Stock Analysis Report
